Discussion & Analysis Q2/2022 Operating Highlights in Q4/2021 Q2/21 Q2/22 Change +/(-) 1H/21 1H/22 Change +/(-) (THB million) %YoY %YoY Operating Revenue 137 230 68% 317 428 35% Gross Profit 77 147 91% 183 267
Discussion & Analysis Q4/2022 Operating Highlights in Q4/2022 Q4/21 Q4/22 Change +/(-) 2021 2022 Change +/(-) (THB million) %YoY %YoY Operating Revenue 188 264 40% 620 938 51% Gross Profit 112 166 48% 355 592
-1- AIT (VP-SEC) 017E/2020 May 11, 2020 Subject: Management's Discussion and Analysis of Operating Results for Q1-2020 To: The President of The Stock Exchange of Thailand Summary of Operations Q1
version shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the information provided in this
Operating Results of the Company in Q3/2019 Q3/18 Q3/19 9M/18 9M/19 Change +/(-) (THB million) YoY 9M Operating Revenue 215 312 45% 620 911 47% Gross Profit 147 202 37% 420 592 41% EBITDA 62 98 58% 161 284 76
operating efficiently and sustainably going forward. 5.2 COVID-19 Impact 5.2.1 Cash Collection Even though the COVID-19 situation started to aggravate since the beginning of March 2020, but most of the
. Management Discussion and Analysis 3.1. Selected Financial Position and Operating Results 3.2. Cash Collection from NPLs and NPAs Management Businesses 3.3. NPLs by Portfolio Concentration 3.4. NPAs
205mn ordinary shares at an offering price of THB 1.60 per share • On 24 April 2019, the shareholder meeting has approved the cash dividend payment from the operating results of the second half of 2018 at
well as medical service concerning health and esthetics. 2. Overview of operating results in the Quarter 1’2018. The global economy has continued its steady growth as a result of a tightening monetary